The interplay between thyroid and liver: implications for clinical practice.
Piantanida E, Ippolito S, Gallo D, Masiello E, Premoli P, Cusini C, Rosetti S, Sabatino J, Segato S, Trimarchi F, Bartalena L, Tanda ML.
J Endocrinol Invest. 2020 Jul;43(7):885-899. doi: 10.1007/s40618-020-01208-6. Epub 2020 Mar 12.
Oral medications.
Albretsen JC.
Vet Clin North Am Small Anim Pract. 2002 Mar;32(2):421-42, vii. doi: 10.1016/s0195-5616(01)00004-3.
Methimazole-induced hepatotoxicity.
Woeber KA.
Endocr Pract. 2002 May-Jun;8(3):222-4. doi: 10.4158/EP.8.3.222.
Leukotriene antagonists.
Davern TJ, Bass NM.
Clin Liver Dis. 2003 May;7(2):501-12, viii. doi: 10.1016/s1089-3261(03)00031-x.
Anastrozole-induced hepatotoxicity.
Zapata E, Zubiaurre L, Bujanda L, Piérola A.
Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1233-4. doi: 10.1097/01.meg.0000243868.64078.af.
Montelukast-induced hepatitis.
Goldstein MF, Anoia J, Black M.
Ann Intern Med. 2004 Apr 6;140(7):586-7. doi: 10.7326/0003-4819-140-7-200404060-00042.
[Tibolone-induced hepatotoxicity].
Blanco Sampascual S, de Las Heras Niño B, Cabezudo Gil P, Ruiz Eguiluz P, Orive Cura V.
Gastroenterol Hepatol. 2002 Apr;25(4):274.
Spironolactone-induced hepatitis.
Thai KE, Sinclair RD.
Australas J Dermatol. 2001 Aug;42(3):180-2. doi: 10.1046/j.1440-0960.2001.00510.x.
Propylthiouracil-induced hepatotoxicity.
Hardee JT, Barnett AL, Thannoun A, Eghtesad B, Wheeler D, Jamal MM.
West J Med. 1996 Sep;165(3):144-7.
Drug-induced liver injury in pregnancy.
Lao TT.
Best Pract Res Clin Obstet Gynaecol. 2020 Oct;68:32-43. doi: 10.1016/j.bpobgyn.2020.03.005. Epub 2020 Mar 16.
